you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Apr 13, 16:00
4780.60 -208.60 (-4.18%)
Volume
AVERAGE VOLUME
5-Day
94,905
10-Day
65,854
30-Day
47,191
166,313
  • Prev. Close

    4989.20

  • Open Price

    5200.00

  • Bid Price (Qty.)

    4780.60 (153)

  • Offer Price (Qty.)

    4804.00 (2)

NSE Live

Apr 13, 15:59
4777.30 -219.65 (-4.40%)
Volume
AVERAGE VOLUME
5-Day
2,117,479
10-Day
1,434,845
30-Day
1,112,862
3,937,234
  • Prev. Close

    4996.95

  • Open Price

    5144.70

  • Bid Price (Qty.)

    4777.30 (1179)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 11,803.00 10,572.90 9,302.60 9,628.10 10,234.80  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 84.20  
Revenue From Operations [Net] 11,803.00 10,572.90 9,302.60 9,628.10 10,150.60  
Total Operating Revenues 11,850.40 10,625.50 9,359.30 9,719.80 10,207.70  
Other Income 743.20 238.40 204.00 591.20 244.80  
Total Revenue 12,593.60 10,863.90 9,563.30 10,311.00 10,452.50  
EXPENSES  
Cost Of Materials Consumed 2,556.50 2,103.20 2,011.00 1,904.60 1,988.50  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 94.20  
Changes In Inventories Of FG,WIP And Stock-In Trade -99.90 66.00 -51.60 1.90 -28.80  
Employee Benefit Expenses 2,030.20 1,931.90 1,843.00 1,803.30 1,710.00  
Finance Costs 47.80 56.80 62.80 57.20 63.80  
Depreciation And Amortisation Expenses 789.20 780.60 774.10 735.10 649.10  
Other Expenses 3,376.80 3,356.10 3,555.40 3,592.90 3,429.40  
Total Expenses 9,817.80 9,163.20 8,866.30 8,766.50 8,516.60  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,775.80 1,700.70 697.00 1,544.50 1,935.90  
Exceptional Items 0.00 0.00 0.00 0.00 -355.90  
Profit/Loss Before Tax 2,775.80 1,700.70 697.00 1,544.50 1,580.00  
Tax Expenses-Continued Operations  
Current Tax 483.90 281.80 138.10 182.60 416.00  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 97.00  
Deferred Tax -645.80 141.60 -8.00 -22.20 -93.50  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses -161.90 423.40 130.10 160.40 225.50  
Profit/Loss After Tax And Before ExtraOrdinary Items 2,937.70 1,277.30 566.90 1,384.10 1,354.50  
Profit/Loss From Continuing Operations 2,937.70 1,277.30 566.90 1,384.10 1,354.50  
Profit/Loss For The Period 2,937.70 1,277.30 566.90 1,384.10 1,354.50  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 177.23 76.98 34.19 83.05 79.42  
Diluted EPS (Rs.) 176.88 76.85 34.12 82.88 79.14  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 766.80  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 1,221.70  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 107.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 322.10  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 391.40 332.00 399.20 335.30 340.50  
Tax On Dividend 0.00 68.20 0.00 0.00 69.30  
Equity Dividend Rate (%) 500.00 400.00 400.00 400.00 400.00  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs